Results 141 to 150 of about 12,143 (160)
The Lancet, 1985 Some of the next articles are maybe not open access.
Related searches:
Related searches:
Agranulocytosis and Ranitidine
Annals of Internal Medicine, 1986Excerpt To the editor: Ranitidine is a histamine-2 receptor antagonist that has been approved for use in the United States since 1983.
openaire +2 more sources
Medical Journal of Australia, 1981
A 63-year-old woman developed anicteric hepatitis after two weeks of therapy with ranitidine. Despite continuation of therapy, her symptoms resolved within five days and transaminase levels returned to normal in the next four weeks, at which time use of the drug ceased.
D. W. Piper, G. D. Barr
openaire +3 more sources
A 63-year-old woman developed anicteric hepatitis after two weeks of therapy with ranitidine. Despite continuation of therapy, her symptoms resolved within five days and transaminase levels returned to normal in the next four weeks, at which time use of the drug ceased.
D. W. Piper, G. D. Barr
openaire +3 more sources
Anaphylactic reaction to ranitidine
Allergy, 1993Ranitidine is a well‐tolerated H2‐receptor antagonist with a furan ring a nucleus. Anaphylactic reactions are seldom reported despite the wide use the drug. We report a patient who presented an anaphylactic reaction with ranitidine (Zantac). The positive skin prick test and oral challenge suggest type I hypersensitivity.
E. Losada +6 more
openaire +3 more sources
Ranitidine and Thrombocytopenia
Journal of Pharmacy Technology, 1995Objective: To provide an overview of thrombocytopenia, focusing on ranitidine-induced thrombocytopenia. Data Sources: References were selected from published bibliographies of books, case reports, and topical searches in the MEDLINE database (English language, through 1994) on thrombocytopenia, ranitidine-induced thrombocytopenia, and cimetidine ...
Josephine M Yim, Jerry L Frazier
openaire +2 more sources
Annals of Internal Medicine, 1986
Excerpt To the editor: Since our previous report (1) we have seen another case of ranitidine-associated hepatitis.
openaire +3 more sources
Excerpt To the editor: Since our previous report (1) we have seen another case of ranitidine-associated hepatitis.
openaire +3 more sources
Annals of Internal Medicine, 1985
Excerpt To the editor: Ranitidine, a recently marketed H2-receptor antagonist, is considered to be effective in the treatment of peptic ulcer disease and other hypersecretory states (1).
openaire +2 more sources
Excerpt To the editor: Ranitidine, a recently marketed H2-receptor antagonist, is considered to be effective in the treatment of peptic ulcer disease and other hypersecretory states (1).
openaire +2 more sources